
201 - 500 employees
Founded 2017
🧬 Biotechnology
💊 Pharmaceuticals
Biotechnology • Pharmaceuticals
Allogene Therapeutics is a clinical-stage biotechnology company headquartered in South San Francisco developing allogeneic chimeric antigen receptor T cell (AlloCAR T) therapies for cancer and autoimmune diseases. The company focuses on immunotherapy and oncology, leveraging off-the-shelf CAR T approaches to create allogeneic cell therapy products targeting hematologic malignancies and potentially autoimmune indications.
🔥 1 minute ago
Specialist in Clinical Supply Chain supporting logistics and shipments for clinical trials at Allogene Therapeutics. Focusing on efficient movement of clinical materials across transport stages.
🔥 1 minute ago
Medical Director overseeing global safety strategy for Allogene CAR T products. Leading pre- and post-marketing safety activities and collaborating with cross-functional teams.
🔥 1 minute ago
Executive Director overseeing market access strategy for Allogene's CAR T therapies. Driving payer engagement, pricing strategy, and reimbursement for oncology treatments.
🔥 1 minute ago
Vice President, Clinical Development leading oncology initiatives at Allogene Therapeutics, a biotech firm specializing in CAR T products. Working cross-functionally to drive clinical trial strategy and execution.
🔥 1 minute ago
Medical Director leading execution of oncology clinical program at Allogene Therapeutics. Focused on driving clinical development strategy with a commitment to life-saving medicines for cancer patients.